About Huxley Medical
Huxley Medical is a private company based in Atlanta, Georgia. It has reported $50,724,329 raised in ten offerings on Form D since June 2021. Its chief executive is Christopher Lee.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sep 30, 2026 | $11,019,335of $11.7M target | 40 | $275K | DebtRule 506(b) | Form D ↗ |
| Apr 17, 2026 | Apr 27, 2026amended Jun 12, 2026 | $2,999,568of $3.0M target | 20 | $149K | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Nov 14, 2025 | Nov 26, 2025amended Feb 12, 2026 | $9,983,145of $10.0M target | 58 | $172K | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| May 28, 2025 | Jun 12, 2025amended Sep 9, 2025 | $1,674,003of $2.0M target | 16 | $104K | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Nov 27, 2024 | Dec 11, 2024 | $4,632,126of $8.0M target | 60 | $77,202 | EquityRule 506(b) | Form D ↗ |
| Feb 16, 2024 | Feb 28, 2024amended Apr 16, 2024 | $5,372,931of $6.0M target | 105 | $51,171 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 26, 2023 | Jun 7, 2023 | $7,216,038of $8.1M target | 85 | $84,895 | EquityRule 506(b) | Form D ↗ |
| Mar 13, 2023 | Apr 26, 2023 | $927,183of $3.5M target | 10 | $92,718 | DebtRule 506(b) | Form D ↗ |
| Jun 29, 2022 | Apr 26, 2023 | $2,900,000of $3.0M target | 52 | $55,769 | DebtRule 506(b) | Form D ↗ |
| Jun 9, 2021 | Jun 29, 2021 | $4,000,000target not set | 59 | $67,797 | Fund interestsRule 506(b) | Form D ↗ |
| Total, ten offerings | $50,724,329 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Huxley Medical's Form D filed Sep 30, 2026.
MP
KJ
Kurt Jacobus
Director
Also a director at Codoxo and CurvaFix and a chairman of the board at EarliPoint Health.
CL
KG
Kenneth Gall
Director
Also a director at Deep Blue Medical Advances and Orthobond and a serial entrepreneur in orthopedic medical device field and director at PROTECT3D.
DB
Drew Beaver
Director
WC
William Cox
Director
BT
Earlier filings also listed Daniel Burnham (executive officer, last listed Jun 2026) and Christopher Hallett (executive officer and director, last listed Dec 2024).